CalmiGo stress device to improve heart blood vessel health
Part of Heart & circulation clinical trials.
This study looks at whether a stress-management device (CalmiGo) can improve blood vessel function and heart disease risk in people recovering from recent heart procedures. You would use the device for 12 weeks and complete questionnaires, blood tests, and a heart-vessel test at the start and end.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You can use the CalmiGo stress device every day for 12 weeks
- You agree to fill out questionnaires and have blood tests at the start and end
- You must be able to do the EndoPat test at the beginning and end of the study
- You recently had a heart event or procedure and are in a cardiac rehabilitation program, or you are being seen for atypical chest pain in the Chest Pain Clinic
- You should not have certain health conditions like unstable heart/lung disease or seizure history
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how to assess small blood-vessel (microvascular) problems in people who had a heart attack but whose main heart arteries are not blocked. It may help doctors better find what’s driving symptoms and choose the right tests and treatments.
This study tests whether using the CalmiGo device, a handheld stress-relief tool, can reduce burnout in healthcare workers. It also looks at changes in voice and speech as signs of stress, to see if they can help measure progress.
This study tests a new kind of stress test to understand how small blood-vessel heart problems relate to heart relaxation problems in people with angina (chest pain) but no blocked arteries. It may help doctors learn better ways to diagnose and guide treatment for these conditions.
This trial studies whether a mindfulness (stress-reducing) program can lower “vascular inflammation” (inflammation in blood vessel walls) in people with stable coronary disease. It may help by improving stress and related inflammation markers while you stay on your usual heart medicines.
This study looks at how stress affects recovery and quality of life in people getting a heart device like a pacemaker or ICD. It aims to help improve care after implantation.
This trial tests how well a heart stress ultrasound (dobutamine echo) can predict if you will get better from a special heart device called cardiac contractility modulation (CCM). CCM is a pacemaker-like implant for people with advanced heart failure who still have symptoms even with the best medicines. The study will help doctors know which patients benefit the most from this device.
Hear when a new Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.